Prof. El Aidy wins Gut Microbiome Therapeutic Innovation challenge
Prof. Sahar El Aidy from the Groningen Biomolecular Sciences and Biotechnology Institute (GBB) has won the ProDigest and CosmosID Gut Microbiome Therapeutic Innovation (GMTI) challenge out of almost fifty submissions from all over the world. Prof. El Aidy won the challenge with her research plan to investigate the ‘Role of anti-Parkinson’s Disease (PD) medication in enhancing bacterial overgrowth and community dynamics along the gastrointestinal tract’. She receives EUR 50,000 to conduct her project on ProDigest’s gastrointestinal SHIME® platform, an in vitro simulator of the gastrointestinal tract.
The aim of the project is to identify which gut bacterial metabolites can improve or impair communication with the host gut-brain axis and effectiveness of drug treatments. According to the reviewing committee, the project of Prof. El Aidy ‘addresses the growing question of the role of the microbiota in the Parkinson’s Disease and of drug-bugs interactions’.
Last modified: | 14 February 2022 3.38 p.m. |
More news
-
07 May 2024
Lecture with soon to be Honorary Doctor Gerrit Hiemstra on May 24
In celebration of his honorary doctorate, FSE has invited Hiemstra to give a lecture entitled ‘Science, let's talk about it’ on the morning of 24 May
-
29 April 2024
Tactile sensors
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
29 April 2024
Behind the scenes: how UG and Hanze UAS students are jointly developing a Mars rover
This year the students of the Makercie team are participating in the physical edition of the European Rover Challenge in Poland. Read more about the team and the collaboration between the RUG and Hanze UAS here.